Oximio is a global end-to-end logistics provider for clinical trials with over 19 years of experience in the industry. Despite the brutal impacts on our Ukrainian founding country in the past year, this has inspired us to strive to deliver not only for the company but...

We are delighted to announce that Oximio Ukraine is represented at the Clinical Trials Subcommittee (CTS) Executive Board at the European Business Association (EBA). Established in 1999, the EBA provides a forum in which members can discuss and find solutions to...

Oximio Community expresses its deepest condolences and supports the communities affected by the earthquake in Türkiye. We can confirm that our Oximio facility in Türkiye has not been affected, however we feel the pain and understand the devastation caused by this...

We are delighted to announce that Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023. “Compassionate use” allows for a patient outside of clinical trials with a serious or life-threatening disease to...

We are delighted to share that expansion of our global bonded depot network continues.  We have successfully received the bonded depot license this week for our Serbia facility. This opens a route for imports of bulk shipments and distribution from our depot in Serbia...

As Oximio patient centricity services continue to expand, we are delighted to announce that the first home healthcare visit in Israel took place week commencing 9th of January 2023.The services allow for the nurses to collect the bio-samples from the patients’...

  Following the announcement of 8th December 2022, the Board of Oximio confirms the appointment of Mykola Nikolaiev as the new Chief Executive Officer (CEO). Accordingly, Krisztina Varga has resigned from the Board as CEO and Mykola Nikolaiev takes over the...

Following the crisis in Ukraine, Oximio has resumed some operations, knowing that previously established supply chains and logistics models are no longer feasible. This is given to the destruction of infrastructure, stock limitations, and most importantly, as we...